Ευρωπαϊκή Ένωση - Πορτογαλικά - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agentes antineoplásicos - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Ευρωπαϊκή Ένωση - Πορτογαλικά - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochloride - fenilcetonurias - outro aparelho digestivo e metabolismo produtos, - kuvan é indicado para o tratamento da hiperfenilalaninemia (hpa) em adultos e pacientes pediátricos de todas as idades com fenilcetonúria (pku) que demonstraram ser sensíveis a esse tratamento. kuvan também é indicado para o tratamento de hyperphenylalaninaemia (hpa) em adultos e pacientes pediátricos de todas as idades, com tetrahydrobiopterin (bh4) a deficiência de que tem sido mostrado para ser ágil para tal tratamento.

Ευρωπαϊκή Ένωση - Πορτογαλικά - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoma, pulmão de células não pequenas - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Πορτογαλία - Πορτογαλικά - DGAV (Direção Geral de Alimentação e Veterinária)

atipamezol 4.27 mg/ml - caninos, felinos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

bayer s.a. - cloridrato de oximetazolina - descongestionantes nasais topicos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

laboratÓrio teuto brasileiro s/a - cloridrato de oximetazolina - descongestionantes nasais topicos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

laboratÓrio teuto brasileiro s/a - cloridrato de oximetazolina - descongestionantes nasais topicos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

brainfarma indÚstria quÍmica e farmacÊutica s.a - cloridrato de oximetazolina - descongestionantes nasais topicos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

prati donaduzzi & cia ltda - cloridrato de oximetazolina - descongestionantes nasais topicos

Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi medley farmacÊutica ltda. - cloridrato de oximetazolina - descongestionantes nasais topicos